Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector

Nature Biotechnology

Volumn 15, Issue 9, 1997, Pages 866-870

  Feng, Meizhen ^a   Jackson, William H ^a   Goldman, Corey K ^a   Rancourt, Claudine ^a   Wang, Minghui ^a   Dusing, Sandra K ^a,c   Siegal, Gene ^a,b   Curiel, David T ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c MA BioServices Inc   (United States)

Author keywords

Chimeric viral vectors; Gene therapy

Indexed keywords

ADENOVIRUS; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; EXPRESSION VECTOR; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS;

ADENOVIRIDAE; ANIMALS; CELL LINE; GENE EXPRESSION REGULATION, VIRAL; GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; RECOMBINANT FUSION PROTEINS; RETROVIRIDAE; TRANSDUCTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; VIRAL PROTEINS;

ADENOVIRIDAE; ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0030775646     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0997-866     Document Type: Article

References (47)

1. Anderson, W.F. 1984. Prospects for human gene therapy. Science 226:401-409.
2. Miller, A.D. 1990. Progress toward human gene therapy. Blood 76:271-278.
3. Felgner, P.L. and Rhodes, G. 1991. Gene therapeutics. Nature 349:351-352.
4. Roemer, K. and Friedmann, T. 1992. Concepts and strategies for human gene therapy. Eur. J. Biochem. 208:211-225.
5. Hannania, E.G., Kavanagh, J., Hortobagyi, G., Giles, R.E., Champlin, R., and Deisseroth, A.B. 1995. Recent advances in the application of gene therapy to human disease. Am. J. Med. 99:537-552.
6. Klein, H.G. 1994. Cellular gene therapy: An overview. J. Clin. Apheres. 9:139-141.
7. Dai, Y., Roman, M., Naviaux, R.K., and Verman, I.M. 1992. Gene therapy via primary myoblasts: Long-term expression of fact IX protein following transplantation in vivo. Proc. Natl. Acad. Sci. USA 89:10892-10895.
8. Wilson, J.M. 1995. Gene therapy for cystic fibrosis: Challenges and future directions. J. Clin. Invest. 96:2547-2554.
9. Rosenfeld, M.A. and Collins, F.S. 1996. Gene therapy for cystic fibrosis. Chest 109:241-252.
10. Fox, J.C. 1996. Cardiovascular gene therapy: Current concepts. Therapeutic Drug Monitoring 18:410-422.
11. Lozier, J.N. and Brinkjous, K.M. 1994. Gene therapy and the hemophilias. JAMA 271:47-51.
12. Haffe, H.A., Danel, C., Longenecker, G., Metzger, M., Setoguchi, Y., Rosenfeld, M.A., et al. 1992. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nature Genetics 1:372-378.
13. Smith, T.A., Mehaffey, M.G., Kayda, D.B., Saunders, J.M., Yei, S., Trapnell, B.C., et al. 1993. Adenovirus-mediated expression of therapeutic plasma levels of human factor IX in mice. Nature Genetics 5:397-402.
14. Morsy, M.A., Alford, E.L., Bett, A., Graham, F.L., Caskey, C.T. 1993. Efficient adenoviral-mediated ornithine transcarbamylase expression in deficient mouse and human hepatocytes. J. Clin. Invest. 92:1580-1586.
15. Herz, J. and Gerard, R.D. 1993. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholersterol clearance in normal mice. Proc. Natl. Acad. Sci. USA 90:2812-2816.
16. Kozarsky, K., Grossman, M., and Wilson, J.M. 1993. Adenovirus-mediated correction of the genetic defect in hepatocytes from patients with familial hypercholesterolemia. Somatic Cell Molec. Gen. 19:449-458.
17. Ishibashi, S., Brown, M.S., Goldstein, J.L., Gerard, R.D., Hammer, R.E., and Herz, J. 1993. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92:883-893.
18. Kozarsky, K.F., Jooss, K., Donahee, M., Strauss, J.F. III, and Wilson, J.M. 1996. Effective treatment of familial hypercholesterolaemia in the mouse model using adenovirus-mediated transfer of the VLDL receptor gene. Nature Genetics 13:54-62.
19. Ye, X., Robinson, M.B., Batshaw, M.L., Furth, E.E., Smith, I., and Wilson, J.M. 1996. Prolonged metabolic correction in adult ornithine transcarbamylase-deficient mice with adenoviral vectors. J. Biol. Chem. 271:3639-3646.
20. Yang, Y., Nunes, F.A., Berencsi, K., Furth, E.E., Gonczol, E., and Wilson, J.M. 1994. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91:4407-4411.
21. Yang, Y. and Wilson, J.M. 1995. Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo. J. Immunol. 155:2564-2570.
22. Yang, Y., Ertle, H.C., and Wilson, J.M. 1995. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1:433-442.
23. Yang, Y., Li, Q., Ertl, H.C., and Wilson, J.M. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:2004-2015.
24. Ferry, N., Duplessis, O., Houssin, D., Danos, O., and Heard, J.-M. 1991. Retroviral-mediated gene transfer in hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 88:8377-8381.
25. Kolodka, T.M., Finegold, M., and Woo, S.L.C. 1993. Hepatic gene therapy: Efficient retroviral-mediated gene transfer into rat hepatocytes in vivo. Somatic Cell Molec. Gen. 19:491-497.
26. Dunckley, M.G., Wells, D.J., Welsh, F.S., and Dickson, G. 1993. Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo. Human Molecular Genetics 2:717-723.
27. Moscioni, A.D., Rozga, J., Neuzil, D.F., Overell, R.W., Holt, J.T., and Demetriou, A.A. 1993. In vivo regional delivery of retrovirally mediated foreign genes to rat liver cells: Need for partial hepatectomy for succcessful foreign gene expression. Surgery 113:304-311.
28. Kolodka, T.M., Finegold, M., and Woo, S.L.C. 1993. Hepatic gene therapy: Efficient retroviral-mediated gene transfer into rat hepatocytes in vivo. Somatic Cell Molec. Gen. 19:491-497.
29. Ram, Z., Walbridge, S., Oshiro, E.M., Viola, J.J., Chiang, Y., Mueller, S.N., et al. 1994. Intrathecal gene therapy for malignant leptomeningeal neoplasia. Cancer Res. 54:2141-2145.
30. Short, M.P., Choi, B.C., Lee, J.K., Malick, A., Breakefield, X.O., and Martuza, R.L. 1990. Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line. J. Neurosci. Res. 27:427-433.
31. Culver, K.W., Ram, Z., Walbridge, S., Ishii, H., Oldfield, E.H., and Blaese, R.M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256:1550-1552.
32. Takamiya, Y., Short, M.P., Moolten, F.L., Fleet, C., Mineta, T., Breakefield, X.O., and Martuza, R.L. 1993. An experimental model of retrovirus gene therapy for malignant brain tumors. J. Neurosurg. 79:104-110.
33. Ram, Z., Culver, K.W., Walbridge, S., Blaese, R.M., and Odfield, E.H. 1993. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res. 53:83-88.
34. Ram, Z., Culver, K.W., Walbridge, S., Frank, J.A., Blaese, R.M., and Oldfield, E.H. 1993. Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors. J. Neurosurg. 79:400-407.
35. Vile, R.G. and Russell, S.J. 1995. Retroviruses as vectors. Brit. Med. Bull. 51:12-30.
36. Miller, AD. 1992. Retroviral vectors. Current topics in microbiology and immunology 158:1-24.
37. Rollins, S.A., Birks, C.W., Setter, E., Squinto, S.P., and Rother, R.P. 1996. Retroviral vector producer cell killing in human serum in mediated by natural antibody and complement: Strategies for evading the humoral immune response. Human Gene Therapy 7:619-626.
38. Pear, W.S., Nolan, G.P., Scott, M.L., and Baltimore, D. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392-8396.
39. Flamant, F., Demeneix, B., Benoist, C., Markossian-Belin, S., and Samarut, J. 1994. Virofection: A new procedure to achieve stable expression of genes transferred into early embryos. Int. J. Dev. Biol. 38:751-757.
40. Morling, F.J. and Russell, S.J. 1995. Enhanced transduction efficiency of retroviral vectors coprecipitated with calcium phosphate. Gene Therapy 2:504-508.
41. Flamant F. and Samarut, J. 1995. Virofection: A one-step procedure for using replication-defective retrovirus vectors. Virology 211:234-240.
42. Finer, M.H., Dull, T.J., Qin, L., Farson, D., and Roberts, M.R. 1994. kat: A high efficiency retroviral transduction system for primary human T lymphocytes. Blood 83:43-50.
43. Noguiez-Hellin, P., Robert-Le Meur, M., Salzmann, J.-L., and Klatzmann, D. 1996. Plasmoviruses: Nonviral/viral vectors for gene therapy. Proc. Natl. Acad. Sci. USA 93:4175-1780.
44. Bett AJ., Haddara W., Prevec L., Graham FL. An efficient and flexible system for-construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc Natl Acad Sci USA 91:8802-6 (1994).
45. Curiel, D.T. 1994. High-efficiency gene transfer employing adenovirus-polylysine-DNA complexes. Natural Immunity 13:141-164.
46. Fisher, K.J., Kelley, W.M., Burda, J.F., and Wilson, J.M. 1996. A novel adenovirus-adeno-associated virus hybrid vector that displays efficient rescue and delivery of the AAV genome. Human Gene Therapy 7:2079-2087.
47. Haapala, D.K., Robey, W.G., Oroszlan, S.D., and Tsai, W.P. 1985. Isolation from cats of an endogenous type C virus with a novel envelope. J. Virology 53:827-833.